Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S).

Diabetes Ther · 2017 · PMC5630555 · PMID 28929327

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Longitudinal Changes in the BMI, Blood Pressure and HbA1c The BMI (or body weight) of the S group did not significantly differ from that at baseline; the BMI (or body weight) of the P group showed an increasing trend from the value at enrollment, but the change was not significant (Table S1).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.